CAS: 183721-15-5 - mrs-1220
Formula:C21H14ClN5O2
InChI:InChI=1/C21H14ClN5O2/c22-14-8-9-16-15(12-14)20-25-19(17-7-4-10-29-17)26-27(20)21(23-16)24-18(28)11-13-5-2-1-3-6-13/h1-10,12H,11H2,(H,23,24,28)
- Synonyms:
- N-(9-chloro-2-furan-2-yl[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-2-phenylacetamide
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE REF: IN-DA00AEBMCAS: 183721-15-5 | 96% | To inquire | Mon 16 Dec 24 |
 | MRS 1220 REF: 3D-FM30704CAS: 183721-15-5 | Min. 95% | To inquire | Mon 27 Jan 25 |
 | MRS1220 REF: TM-T23016CAS: 183721-15-5 | 96.59% | To inquire | Mon 03 Feb 25 |
![9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE](https://static.cymitquimica.com/products/IN/thumb/DA00AEBM.jpg)
9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE
CAS:183721-15-5
Formula:
C21H14ClN5O2
Purity:
96%
Color and Shape:
Solid
Molecular weight:
403.8212
Ref: IN-DA00AEBM
| 1mg | 133.00 € | ||
| 5mg | 225.00 € | ||
| 10mg | 479.00 € | ||
| 25mg | 533.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 500mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
MRS 1220
CAS:183721-15-5
Antagonist of adenosine receptor A3
Formula:
C21H14ClN5O2
Purity:
Min. 95%
Molecular weight:
403.82 g/mol
Ref: 3D-FM30704
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 250µg | To inquire | ||
| 500µg | To inquire |
Estimated delivery in United States, on Monday 27 Jan 2025
MRS1220
CAS:183721-15-5
MRS1220, a selective and potent antagonist for the human A3 adenosine receptor (hA3AR) with a …
Formula:
C21H14ClN5O2
Purity:
96.59%
Color and Shape:
Solid
Molecular weight:
403.82
Ref: TM-T23016
| 1mg | 49.00 € | ||
| 5mg | 114.00 € | ||
| 10mg | 174.00 € | ||
| 25mg | 297.00 € | ||
| 50mg | 428.00 € | ||
| 100mg | 603.00 € | ||
| 500mg | To inquire |
Estimated delivery in United States, on Monday 3 Feb 2025
